Lasa Supergenerics gets environmental clearance for Benzimidazole Derivatives Capacity Expansion

04 Nov 2020 Evaluate

Lasa Supergenerics has received the ‘environmental clearance’ from the State Environment Impact Assessment Authority (SEIAA) for expanding its ‘benzimidazole derivatives’ capacity at the company’s manufacturing facility at Khed, Maharashtra.

The proposed expansion will require only a de-bottlenecking capex as the company already has the necessary infrastructure and machinery in place and was awaiting environmental clearance to operationalize the assets. 

Lasa Supergenerics is pioneer and amongst the leading players in the manufacturing of APIs in India through its catalyst chemistry expertise and fully backward integrated unit.

Lasa Supergenerics Share Price

9.90 -0.10 (-1.00%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×